Document is current
Any future updates will be listed below
-
Authors
Tan, Mark K. I.
de Jesus, Myrela C. S.
Phelan, Jody E.
Thorpe, Joseph
Ward, Daniel
Batra, Rahul
Patel, Amita
Nolder, Debbie
Chiodini, Peter
Sutherland, Colin J.
Edgeworth, Jonathan
Clark, Taane G.
Campino, Susana
-
Funding
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2024/07850-4)
UK Health Security Agency
Biotechnology and Biological Sciences Research Council (BB/X018156/1)
Medical Research Council (MR/R020973/1)
Engineering and Physical Sciences Research Council (EP/Y018842/1)
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 23 October 2025
First Online: 19 December 2025
Declarations
:
: The processing of anonymized clinical samples by the UKHSA-MRL/LSHTM for the proposed project has been approved by The UK National Research Ethics Service (Ref: 18/LO/0738) and LSHTM Research Ethics Committee (Ref: 14710).
: Not applicable.
: JE is employed part time by Oxford Nanopore Technologies as VP Medical Affairs.
